Molecular staging of melanoma

Annals of Surgical Oncology

Volumn 11, Issue 11, 2004, Pages 953-954

  Shivers, Steve ^a   Alsarraj, Marwan ^a   Guiliano, Rosemary ^a   Jakub, James ^a   Pendas, Solange ^a   Reintgen, Douglas ^a  

^a Lakeland Regional Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLINICAL TRIAL; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; MELANOMA; METASTASIS; CLASSIFICATION; GENETICS; LYMPH NODE METASTASIS; METHODOLOGY; NOTE; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

DNA;

DNA, NEOPLASM; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 16644388755     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.09.914     Document Type: Editorial

References (16)

1. Gradilone A, Ribuffo D, Silvestri I, et al. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase polymerase chain reaction: prognostic significance. Ann Surg 2004;11:983-987.
2. Ruka W, Rugkowski P, Nowecki ZI, et al. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients using two-marker reverse transcriptase-polymerase chain reaction (RT-PCR) assay. Ann Surg 2004;11:988-997.
3. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
4. Heller R, Wassalle J, Becker J, et al. The detection of submicroscopic lymph node metastases in patients with malignant melanoma. Arch Surg 1991;126:1455-60.
5. Heller R, King B, Baekey P, et al. The identification of submicroscopic lymph node metastases in patients with malignant melanoma. Semin Surg Oncol 1993;9:285-9.
6. Wang X, Heller R, Cruse CW, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
7. Shivers S, Wang X, Li W, Rapaport D, et al. Molecular staging of malignant melanoma. Correlation with clinical outcome. JAMA 1998:280:1410-5.
8. Kuo CT, Hoon DS, Takeuchi H, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol 2003;21:3566-72.
9. Palmieri G, Pirastu M, Strazzulo M, et al. Clinical significance of PCR-positive mRNA markers in the peripheral blood and regional nodes of malignant melanoma patients. Recent Results Cancer Res 2001;158:200-3.
10. Blaheta HJ, Ellwanger U. Schittek B, et al. Examination of regional lymph nodes by sentinel lymph node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637-42.
11. Ribuffo D, Gradilone A, Vonella M, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol 2003;10:396-402.
12. McMasters KM. The SunBelt Melanoma Trial. Ann Surg Oncol 2001;8:41-3.
13. Bieligk SC, Ghossein R, Bhattacharya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999;6:225-6.
14. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17:3238-44.
15. Goydos JS, Ravikumar TS, Germino FJ, et al. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998 Aug;187:182-8; discussion 188-90.
16. Goydos JS, Yudd AP, Kempf JS, et al. Patterns of recurrence in patients with melanomas and histologically negative but RT-PCR positive sentinel lymph nodes. Am Coll Surg 2001 (Abstract).